Prostate Cancer - Results from #300

The impact of progression-directed therapy on survival in metastatic castration-refractory prostate cancer: MEDCARE phase 3 trial. November 8, 2024

Multidimensional Healthcare Access Barriers to Prostate-Specific Antigen Testing: A Nation-Wide Panel Study in the United States From 2006 to 2020. November 7, 2024

Cribriform Pattern Is a Predictive Factor of PSA Recurrence in Patients Receiving Radiotherapy After Prostatectomy. November 7, 2024

Prognostic Expression Signature of RB1, PTEN, and TP53 Genes in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors. November 7, 2024

Follow-up on patients with initial negative mpMRI target and systematic biopsy for PI-RADS ≥ 3 lesions - an EAU-YAU study enhancing prostate cancer detection. November 7, 2024

PSA Kinetics Affect Prognosis in Patients With Castration-resistant Prostate Cancer Treated With Enzalutamide. November 7, 2024

Nutraceuticals target androgen receptor-splice variants (AR-SV) to manage castration resistant prostate cancer (CRPC). November 6, 2024

Assessing racial differences in time to subsequent treatment following androgen deprivation therapy among Veterans with prostate cancer. November 6, 2024

Statin use and oncological outcomes in a propensity-matched cohort of nonmetastatic castration resistant prostate cancer patients of the ARAMIS trial. November 6, 2024

Association of race with incidence, characteristics, and mortality from incidental prostate cancer: Analysis of two North American contemporary cohorts. November 6, 2024

AI-ADC: Channel and Spatial Attention-Based Contrastive Learning to Generate ADC Maps from T2W MRI for Prostate Cancer Detection. November 6, 2024

Assessment of Different Castration Resistance Definitions and Staging Modalities in Metastatic Castration-Resistant Prostate Cancer. November 6, 2024

Evaluating the Importance of Practice-Level Factors on Adherence to Prostate Cancer Treatment Guidelines in Urology. November 5, 2024

County-level racial disparities in prostate cancer specific mortality from 2005 to 2020. November 5, 2024

The Complex Challenge of Urosymphyseal Fistula and Pubic Osteomyelitis in Prostate Cancer Survivors. November 5, 2024

Pesticides and prostate cancer incidence and mortality: An environment-wide association study. November 5, 2024

Olaparib plus Abiraterone for Metastatic Castration-resistant Prostate Cancer: Pharmacokinetics Data from the PROpel Trial. November 5, 2024

The association between patient characteristics, psychological distress, and coping in the diagnostic phase of prostate cancer – A cross-sectional multicenter study November 4, 2024

In Major Win for Patients, CMS Adjusts Nuclear Medicine Reimbursement Policy, Expanding Access to Life-Saving Scans November 4, 2024

Oncogenic Alterations, Race, and Survival in US Veterans with Metastatic Prostate Cancer Undergoing Somatic Tumor Next Generation Sequencing. November 4, 2024

Page 16 of 1451